Concepedia

Amitai D. Mandelbaum

AD

8

Publications

738

Citations

8

H-Index

2011

Active since

Affiliations

Weizmann Institute of Science(Current)

Integrated DNA Technologies (United States)

Hebrew University of Jerusalem

Amitai D. Mandelbaum is an author at Weizmann Institute of Science specializing in medicine, gene expression, and cell signaling.

Top concepts

MedicineCell BiologyCell SignalingNon-coding RnaGene ExpressionNatural SciencesGene RegulationSystems BiologyDevelopmental BiologyEpigenetic Regulation

Publications per year

2011–2019

8

Publications

8

miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors

Tal Melkman-Zehavi, Roni Oren, Sharon Kredo‐Russo et al. · The EMBO Journal · 2011 · 281 citations · Full text

Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles

Michal Bachar, Amitai D. Mandelbaum, Irina Portnaya et al. · Journal of Controlled Release · 2012 · 145 citations

Nanoparticles, Nanomedicine, Engineering +10

Pancreas-enriched miRNA refines endocrine cell differentiation

Sharon Kredo‐Russo, Amitai D. Mandelbaum, A. T. Ness et al. · Development · 2012 · 108 citations

Endocrine Cell Differentiation, Epigenetics, Transcriptional Regulation +18

Dysregulation of Dicer1 in Beta Cells Impairs Islet Architecture and Glucose Metabolism

Amitai D. Mandelbaum, Tal Melkman-Zehavi, Roni Oren et al. · Experimental Diabetes Research · 2012 · 60 citations · Full text

Mirnas Activity, Metabolic Remodeling, Insulin Signaling +16

Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology

Irit Reichenstein, Chen Eitan, Sandra Díaz-García et al. · Science Translational Medicine · 2019 · 59 citations · Full text

Rows per page

1–5 of 8